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Dentato-rubral and pallido-luysian atrophy (DRPLA) is a dominant, progressive neurodegenerative disease caused by the expansion of
polyglutamine repeats within the human Atrophin-1 protein. Drosophila Atrophin and its human orthologue are thought to function as
transcriptional co-repressors. Here, we report that Drosophila Atrophin participates in the negative regulation of Epidermal Growth Factor
Receptor (EGFR) signaling both in the wing and the eye imaginal discs. In the wing pouch, Atrophin loss of function clones induces cell
autonomous expression of the EGFR target gene Delta, and the formation of extra vein tissue, while overexpression of Atrophin inhibits EGFR-
dependent vein formation. In the eye, Atrophin cooperates with other negative regulators of the EGFR signaling to prevent the differentiation of
surplus photoreceptor cells and to repress Delta expression. Overexpression of Atrophin in the eye reduces the EGFR-dependent recruitment of
cone cells. In both the eye and wing, epistasis tests show that Atrophin acts downstream or in parallel to the MAP kinase rolled to modulate EGFR
signaling outputs. We show that Atrophin genetically cooperates with the nuclear repressor Yan to inhibit the EGFR signaling activity. Finally, we
have found that expression of pathogenic or normal forms of human Atrophin-1 in the wing promotes wing vein differentiation and acts as
dominant negative proteins inhibiting endogenous fly Atrophin activity.
© 2005 Elsevier Inc. All rights reserved.Keywords: Drosophila; Atrophin; DRPLA; EGFR signaling; Cell signaling; YanIntroduction
Dentato-rubral and pallido-luysian atrophy (DRPLA) is an
autosomal dominant, progressive neurodegenerative disease
with symptoms similar to those of Huntington's disease (HD)
such as chorea, ataxia, incoordination and dementia (Naito and
Oyanagi, 1982; Ross et al., 1997a,b; Smith et al., 1958). DRPLA
is caused by expansion of a CAG repeat in the coding region of
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doi:10.1016/j.ydbio.2005.12.012the cytoplasm and the nucleus, where it acts as a transcriptional
co-repressor (Wood et al., 2000). Truncated fragments of
Atrophin-1, containing the expanded polyglutamine tract, have
been shown to accumulate in populations of neuronal nuclei,
both in a mouse model of DRPLA and in human DRPLA brain
tissue (Schilling et al., 1999). Several observations indicate that
these fragments may underlie the pathogenesis of the disease
(Nucifora et al., 2001, 2003). Little is known, however, about the
physiological role of Atrophin-1.
The Drosophila Atrophin (Atro) homologue acts as a
transcriptional co-repressor in multiple developmental process-
es. Segmentation is abnormal inAtro−mutant embryos, resulting
from the lack of repression of the segmentation genes (Erkner et
al., 2002; Zhang et al., 2002). In addition, Atro− embryos display
a ventralized phenotype and neurogenic defects, suggesting a
requirement for Atro in both dorso-ventral patterning and
neurogenesis (Zhang et al., 2002). In the adult, Atro− clones
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(Zhang et al., 2002). In the eye, Atro activity is required to ensure
proper planar polarity, ommatidial rotation and photoreceptor
(PR) cell recruitment (Fanto et al., 2003; Zhang et al., 2002).
Atro− clones located in the proximal region of the legs develop
distal structures, cause defects in leg segmentation and
patterning especially in ventral parts (Erkner et al., 2002). In
all these tissues, Atro is also required for proper planar cell
polarity (Fanto et al., 2003; Zhang et al., 2002). Remarkably,
many of these adult phenotypes resemble those caused by
upregulation of Epidermal Growth Factor Receptor (EGFR)
signaling (Brown and Freeman, 2003; Campbell, 2002; Diaz-
Benjumea and Hafen, 1994; Dominguez et al., 1998; Freeman,
1996; Galindo et al., 2002; Strutt and Strutt, 2003), raising the
possibility that Atro plays a role in the EGFR pathway for proper
patterning of the imaginal discs. In support of this idea, we have
isolated Atro mutations as genetic modifiers of Drosophila
EGFR signaling (this work).
The Drosophila EGFR signaling pathway controls multiple
processes during development, such as cell fate, proliferation,
survival, migration, adhesion and ommatidial rotation (Freeman,
1996; Shilo, 2003; Wolff, 2003). Despite its widespread function,
EGFR signaling usually involves a common cytoplasmic cascade
including Ras, and the serine–threonine kinases Raf, MAPKK/
MEK and the MAPK rolled (rl) (reviewed by (Perrimon and
Perkins, 1997). Activated MAPK transmits the RAS cascade
signal into the nucleus by phosphorylating two members of the
ETS family of transcription factors, Yan (also called Aop-Flybase,
Rebay and Rubin, 1995) and Pointed (Pnt) (Brunner et al., 1994a;
O'Neill et al., 1994). Yan is a transcriptional repressor that moves
to the cytoplasm for degradation upon phosphorylation induced by
EGFR signaling (Rebay and Rubin, 1995). The pnt gene encodes
for two related proteins, PntP1 and PntP2, with PntP1 acting as a
constitutive activator of transcription, while the activity of PntP2 is
stimulated by the Ras/MAPK pathway (O'Neill et al., 1994). The
role of EGFR signaling in cell differentiation has been extensively
studied during development of both the eye and wing of
Drosophila, where EGFR controls cell recruitment and vein
differentiation, respectively. In both tissues, EGFR promotes the
expression of several target genes including Delta (Dl) and argos
(Golembo et al., 1996b; Martin-Blanco et al., 1999; Sawamoto et
al., 1994; Tsuda et al., 2002).
We investigated the possibility that Atro plays a major role in
the EGFR pathway during imaginal disc development of
Drosophila. We found that Atro inhibits EGFR signaling both
in the wing and eye imaginal discs from the third instar onwards
(i.e. not for the earlier proximal distal wing patterning; Baonza et
al., 2000; Wang et al., 2000; Zecca and Struhl, 2002a,b). In the
wing pouch, Atro loss of function clones induce cell autonomous
expression of the EGFR target gene Dl, and the formation of
extra vein tissue, while overexpression of Atro inhibits EGFR-
dependent vein formation. Atro also acts as a negative regulator
of EGFR in the eye. Overexpression of Atro in the eye reduces
the EGFR-dependent recruitment of cone cells. In both the eye
and wing, epistasis tests show that Atro acts downstream or in
parallel to the MAP kinase rolled to modulate EGFR signaling
output. Interestingly, expression of a truncated form of humanAtrophin-1 in the wing causes similar phenotypes to those
produced by the ectopic activation of EGFR signaling.
Materials and methods
Genetic strains
Atro alleles are described in Erkner et al. (2002), except for Atro14967. The P-
element P(w+)14967 is located in the 5′ UTR of the Atro gene, at position
8428981. The P element came from the lethal insertions on the 3 chromosome of
Szeged collection. The exact position of the insertion was analyzed following the
standard protocols for inverse PCR for sequencing of P element insertions
available in http://www.fruitfly.org/about/methods/. The 3′ flanking sequence of
the Pelement is: TCATCATGGTACTAAGGGACTAATGGTAACGGACACA-
CACACATACACACACACACACCCAGAGAGAGAGAGAGAGAGA-
GAAAAAGCCGCAGACTACAGAATTGGCTGGATACTTATGGTG-
CAAAAAGGGGGGGATGGAGGTTGTGAACAAGAGGATGTGGATGTG-
GATGAGGAAAAGGCGGACGGGGGGACGGCGTGCAAAATGAT-
GAAGGTATCTACACCGACAATCTGTTTAACAACTTCATGAGCAAATC-
CAACAAATCGTATGAAACGAAGCCGACAGCAGGCCAACAGCACA-
GACACGAGCGGACGTCGTTGTATTACGATTTGGACTCGGATTCG-
GATTCAGATTCAGATTCGGATTCGGATTCAGTTTCGGATGCAGAC-
GAG. The following are the sources of the stocks used in this study: rlSem, styΔ5,
UAS-YanWT, pntΔ88, pnt1277, pnt07825 (Bloomington stock center), cic2, cicbwkΔ11
(Roch et al., 2002), UAS-EGFRACT (Queenan et al., 1997), UAS-EGFRDN
(Freeman, 1996), dpp-Gal4 (Staehling-Hampton et al., 1994), UAS-Atro (this
work),GMR-argos, sev-rho, rhoPΔ5, vn10567, ru1, rho7M43 and argos1Δ7. All these
alleles are described in Flybase (http://flybase.bio.indiana.edu/).
Clone induction
Mitotic clones were generated by FLP-mediated mitotic recombination (Xu and
Rubin, 1993). In all cases, recombination was induced in second instar larvae (60h
AEL) by a 90 min heat shock at 37°C. In the eye, mutant clones for Atro14967,
argos1Δ7, argos1Δ7 Atro14967, ru rho7M43 argos1Δ7 Atro14967 and sprouty Atro14967were
marked by the absence of GFP, using y w hsp-FLP122; ubi-GFP M(3)i55 FRT80B /
TM6B stock. These flies were crossed to: Atro14967 FRT80B/TM6B, orw hsp-FLP122;
argos1Δ7FRT80B/TM6B, or argos1Δ7 Atro14967 FRT80B/TM6B, or ru rho7M43
argos1Δ7Atro14967FRT80B/TM6B. Clones in adult wings were obtained by crossing
y w hsp-FLP122;mwhAtroX FRT2A/TM6B females (whereX= 1207D6, 35, PZ3928,
14967) to y w; Dp(1;3)scJ4, y+ M(3)i55 FRT2A/TM3 males. For induction of Atro−
clones inwing discs: female y w hsp-FLP122; ubi-GFPFRT2A/ubi-GFPFRT2Awere
crossed to male y w hsp-FLP122; vgBE-lacZ/CyO wg-LacZ; Atro35 FRT2A/TM6B or
male y w hsp-FLP122; vgQ-lacZ/CyO wg-LacZ; Atro35 FRT2A/TM6B. Mutant clones
for rhoPΔ5vn Atro14967 were obtained by crossing y w hsp-FLP122; ubi-GFP M(3)i55
FRT80B /TM6B flies to mwh rhoPΔ5vn Atro14967FRT80B/TM6B. In all cases, mutant
clones were identified by absence of GFP or the multiple wing hair (mwh).
Induction of clones lacking Atro and expressing Nintra was obtained by crossing
y w hsp-FLP122; arm-GAL4/arm-GAL4; mwh Atro35FRT2A/TM6B flies to y w hsp-
FLP122; UAS-Nintra/UAS-Nintra; tubP-GAL80 FRT2A/TM6B. Progeny were heat
shocked at 36°C for 2 h between 48 and 72 or 72 and 96 h after egg laying. Clones
lacking Atro and expressing Nintra were identified by the mwh marker. Su(H)−
mutant clones were obtained by crossing females y w hsp-FLP122; ubi-GFP
FRT40A/ubi-GFP FRT40A to male Su(H)del47 FRT40A/CyO wg-LacZ.
Histology
Scanning electron micrographs were prepared as described by Kimmel
et al. (1990). Whole adult eyes were examined using a Leica MZFLIII
stereomicroscope and processed with ACT-1.LNK image analysis software
from Nikon. Adult wings and legs were dissected in 100% ethanol, rinsed
twice in xylene, mounted in DPX and observed under a Zeiss AxioPhot
microscope using Normarski optics. Immunohistochemical staining of
imaginal discs and pupal discs (45 h after puparium formation) was
performed as follows. Imaginal discs were dissected in PBS, 0.1% Triton
X100 (PBT), and fixed for 15 min in 4% paraformaldehyde in PBT, washed
(3 × 15 min each), blocked in PBT, 0.1%BSA for 1 h and incubated in the
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the following antibodies: mouse anti-Arm (1/100) (hybridoma—from
DSHB), rat anti-Elav (1/10) (hybridoma-supernatant 7E8A10 from DSHB),
rabbit anti-Atonal (1/500) (Jarman et al., 1993), mouse anti-Cut (1/10)
(hybridoma-supernatant ZB-10 from DSHB), mouse anti-Delta (1/10)
(hybridoma-supernatant C594-9B from DSHB), rabbit anti-β-galactosidase
(1/1000) (Cappel ICN-Pharmaceuticals Inc.), mouse anti-dpERK (1/100)
(SIGMA), rabbit anti-human Atrophin-1 APG840 (1/500) (Wood et al.,
2000), rabbit anti-Atro (1/500) (Erkner et al., 2002), rabbit anti-Distal-less
(1/200) (a gift from S. Carroll), rabbit anti-Vestigial (1/200) (a gift from S.
Carroll) or mouse anti-Wingless (1/10) (hybridoma-supernatant 4D4 from
DSHB). Secondary antibodies were TRITC-conjugated AffiniPure Donkey
anti-IgG from Jackson ImmunoResearch used at a 1/400 dilution. A Zeiss
confocal microscope was employed for capture of images.
Plasmid construction
A 6 kb cDNA containing the entire Atro open reading frame was cloned in
the pUAST transformation vector (Brand and Perrimon, 1993) to generate UAS-
Atro. Ubiquitous expression of UAS-Atro (with arm-GAL4) rescues the
embryonic lethality of Atro35/AtroPZ3928 mutants. To create ubi-GFP-Atro, a
GFP-Atro fusion cDNAwas cloned into the transformation vector pCaSpeR-UP
(Davis et al., 1995). The embryonic lethality of homozygous Atro35 or
AtroPZ3928 is rescued in presence of the ubi-GFP-Atro transgene. Truncated
Atrophin-1 cDNAs encoding the first 917 amino acids (At-N917-26Q or At-
N917-65Q) were generated by PCR using full-length human Atrophin-1 cDNAs
(At-FL-26Q or At-FL-65Q, a gift from David R. Borchelt; Schilling et al., 1999)
as templates, and cloned into pUAST to generate UAS-At-N917-26Q or UAS-At-
N917-65Q. For each construct, several transgenic lines were generated by P-
element-mediated transformation (Spradling and Rubin, 1982). UAS lines
expressing similar amounts of human Atrophin 1 proteins under GMR-Gal4
control were identified and used here.
Detailed construct information is available upon request.
Results
Atrophin inhibits EGFR signaling
We used a genetic modifier screen to identify new components
of EGFR signaling. A P-element induced mutation, P(w+)14967,Fig. 1. Atro interacts with mutations of the EGFR pathway. (A) Wild-type eye. (B) O
rough eye phenotype (sev-rho/+). (C) Atro35 heterozygotes enhance the sev-rho, ex
under the control of the GMR enhancer causes a rough eye phenotype (GMR-argos/
phenotype (GMR-argos/Atro35). (F) Wild-type wing. (G) The gain-of-function rolle
AtroPZ03928 heterozygotes enhance the ectopic vein phenotype of rlSem/+(rlSem/+; Atro
Atro under the control of the ubiquitin promoter (ubi-GFP-Atro/ubi-GFP-Atro).was found to enhance the rough eye caused by the misexpression
of rho (Figs. 1B–C), a specific activator of EGFR signaling (Bier
et al., 1990; Golembo et al., 1996a; Lee et al., 2001; Urban et al.,
2001). P(w+)14967 is located in the 5′ UTR of the Atro gene and
fails to complement other Atro alleles, Atro35, AtroPZ3928 and
Atro12O7D6 (Erkner et al., 2002). All these Atro loss of function
alleles also behave as enhancers of rho misexpression in the eye
(see Table 1). This enhancement suggests that Atro is an inhibitor
of EGFR signaling. Further genetic tests provide evidence that
Atro interacts with the EGFR pathway. First, halving the dose of
Atro suppresses the rough eye caused by overexpressing Argos
(Figs. 1D–E), a negative regulator of the EGFR signaling
(Freeman et al., 1992; Schweitzer et al., 1995; Vinos and Freeman,
2000). Second, halving Atro enhances the extra wing-vein
phenotype caused by the constitutively active MAPK mutation
rolledSevenmaker (rlSem) (Figs. 1G–H and Brunner et al., 1994b), and
ubiquitous overexpression of Atro weakly suppresses vein diffe-
rentiation (Fig. 1I). Third, ectopic wing-veins differentiate in wings
transheterozygous for Atro and mutations in genes acting as nega-
tive regulators of EGFR signaling (sprouty (sty) and capicua (cic),
data not shown). Fourth, simultaneous expression of Atro and Yan,
a nuclear repressor of EGFR signaling, cooperates genetically to
counteract EGFR signaling in both the wing and the eye (see
below). These results indicate that Atro inhibits EGFR signaling.
Atrophin regulates photoreceptor cell recruitment in the eye
The Drosophila compound eye is composed of approxi-
mately 800 ommatidia, each of which contains eight
photoreceptor (PR) cells (R1–R8), four non-neuronal cone
cells and eight accessory cells arranged in a highly ordered
pattern. The EGFR signaling pathway is required for the
recruitment and differentiation of cone cells and all PR cell
types in the eye, with the exception of R8 (Dominguez et al.,
1998; Freeman, 1996). Loss of function alleles of negativeverexpression of rhomboid under the control of the sevenless promoter causes a
cess EGFR signaling, phenotype (sev-rho/Atro35). (D) Overexpression of argos
+). (E) Atro35 heterozygotes suppress the GMR-argos, loss of EGFR signaling,
dSevenmaker (rlSem) mutation induces the formation of ectopic vein material. (H)
PZ03928/+). (I) Partial vein suppression is observed following expression of GFP-
Table 1
Genetic interactions between atrophin and members of the Egfr pathway
Genotype sev-rho/+ GMR-argos/+ rlsem/+
Eye Eye Wing
AtroPZ3928/+ ++ nd ++
Atro1207D6/+ ++ nd ++
Atro35/+ ++ − − +
Atro14967/+ + − +
UAS-Atro/GMR-Gal4 − − ++ nd
UAS-Atro/dpp-Gal4 nd nd − −
Ubi-GFP-Atro/Y − nd − −
Enhancement (+). Supression (−). Not determined (nd).
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extra cone cells and PRs (Casci et al., 1999; Freeman et al.,
1992). For instance, clones mutant for argos develop extra
PRs: in argos− clones, we observed 46.2% ommatidia with
8 PRs, 40.7% with 9 PRs, 11.1% with 10 PRs and 1.8% with
11PRs (Figs. 2A and D and Freeman et al., 1992). This
phenotype is strongly enhanced in clones mutant for bothFig. 2. Atro loss of function phenotypes. (A–E) Atro cooperates with argos to repress
argos−Atro− (C) in eye imaginal discs, detected by the absence of GFP (green), and s
autonomous recruitment of PR cells in argos−Atro− cells when compared to argos− (A
PR cells (marked with Anti-Elav (red)) in an argos− clone (detected by the absence of
cells (marked with Anti-Elav (red)) in an argos−Atro− clone (detected by the absence
imaginal disc with an argos−Atro− clone (marked by absence of GFP, green) stained w
in argos−Atro− mutant cells in each ommatidium. (G) Ectopic cone cells are formed
Arm to outline the cone cells. The whole panel shows mutant cells for Atro. Ommatidi
with 3 cone cells. (H) Loss of Atro activity in the wing promotes ectopic vein formatio
extra wing-vein material (H). Inset: magnification of the area showed in panel H sho
are marked with multiple wing hairs (mwh).Atro and argos, where numerous additional PRs differentiate:
in argos− Atro− clones, there are 11.1% ommatidia with less
than 6 PRs, 7.4% with 7 PRs, 14% with 8 PRs, 19.2% with 9
PRs, 14% with 10 PRs, 11.8% with 11 PRs, 8.1% with 12
PRs and 14% with more than 12 PRs (Figs. 2C and E). This
phenotype is similar to the phenotype observed in double
mutant clones for argos and sty, two negative regulators of
the EGFR (Casci et al., 1999). This result indicates that Atro
and argos genetically cooperate to antagonize EGFR activity.
A similar result is obtained in mutant clones for both Atro and
sty (data not shown). Note that no additional PR cells are
formed in Atro− clones (see Fig. 2B). To exclude that the
extra PRs observed in the argos− Atro− clones are R8 cells,
which are independent of EGFR signaling (Dominguez et al.,
1998; Freeman, 1996), third instar eye discs with these clones
were stained with anti-Atonal, an R8-specific antibody. Single
R8 cells are seen in each mature ommatidium in argos− Atro−
clones (Fig. 2F). In addition, we found that mutant clones for
Atro can occasionally induce ectopic cone cells, which are
also recruited by EGFR signaling (Freeman, 1996): 65.2% ofrecruitment of PR cells. (A–C) Clones homozygous for argos− (A), Atro− (B) or
tained with anti-Elav (red) to mark all PR cells. (C) Note the great excess of cell
) or Atro− (B) clones. (D) A pupal disc showing several ommatidia with excess
GFP). (E) A pupal disc showing several ommatidia with a massive excess of PR
of GFP). (F) Recruitment of the PR R8 is not affected in argos−Atro− cells. Eye
ith anti-Atonal (red) to mark R8 PRs. Single R8 type PRs (red in F) are detected
in absence of Atro activity. Pupal eye disc with an Atro− clone stained with anti-
a with 5 cone cells are labeled with an asterisk. The dot indicates an ommatidium
n. An adult wing with Atro− clones induced at 48–72 h after egg deposition show
wing the autonomous effect of Atro− clones on vein differentiation. Atro− clones
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have 5 cone cells, 14.7% only have 3 (Fig. 2G). Consistent
with these data in the eye, Atro also acts as a suppressor of
EGFR signaling in the wing. Atro35 clones marked with
multiple wing hairs (mwh) develop extra vein tissue
autonomously in the adult wing (Fig. 2H). We obtained
similar results with other alleles: AtroPZ3928, Atro12O7D6 and
Atro14967 (data not shown). Autonomous differentiation of
vein tissue is also observed in clones induced later during
development (48 to 72h, Fig. 2H, and 72 to 96 h AED, data
not shown). Thus, both in the eye and in the wing, Atro−
clones show phenotypes diagnostic of excessive EGFR
activity, implying a normal function for Atro in restricting
EGFR signaling.
Overexpression of Atrophin mimics loss of EGFR signaling
Our results imply that Atro negatively regulates EGFR
signaling. In accordance with this hypothesis, overexpression
of UAS-Atro in the eye, using the GMR-Gal4 driver,
suppresses the Rhomboid misexpression phenotype (Figs.
3A–C) and enhances the rough eye phenotype caused by
Argos overexpression (Figs. 3D–F). In addition, overexpres-
sion of Atro in the eye reduces the number of cone cells that
are recruited to each ommatidium, while PR recruitment is
normal: 76% of the ommatidia contain 3 cone cells, 8% have
2 cone cells and 15% are normal (Figs. 3G–I and data not
shown). This is consistent with previous work showing that
recruitment of cone cells is more sensitive than recruitment of
PRs to deregulation of EGFR signaling (Freeman, 1996). In
the wing, the overexpression of Atro in prospective veins
driven by the line 580-Gal4 causes a substantial loss of wing
vein tissue and a reduction in wing size (Fig. 3K). In legs,
overexpression of Atro using the dpp-Gal4 driver promotes
fusion of the tarsus whereas the rest of the leg is normal (Fig.
3M). Reduction of EGFR activity in legs displays a similar
phenotype (Campbell, 2002; Galindo et al., 2002). Atrophin
therefore acts as a negative regulator of EGFR signaling in a
variety of processes during imaginal disc development. Note
that ubiquitous expression of UAS-Atro with arm-Gal4
rescues the embryonic lethality of AtroPZ3928/Atro35 transhe-
terozygous (data not shown), showing that UAS-Atro
produces a functional Atro protein.
Atrophin is a repressor of the EGFR target gene Delta
In third instar imaginal discs, the expression of Dl is
positively regulated by the EGFR signaling pathway, both in
the wing pouch and in PR cells of the eye (Tsuda et al.,
2002). We investigated whether Atro represses the expression
of Dl. In the eye disc, whereas the expression of Dl is
unchanged (or slightly increased) in Atro− clones (Fig. 4A),
Atro− argos− clones display high levels of Dl expression (Fig.
4C) when compared to wild-type cells or argos− clones (Fig.
4B). Atro activity therefore contributes to the repression of Dl
in the eye in a cell autonomous manner. This result is
consistent with the effect of Atro− clones on PR recruitment(see above) and indicates that Atro has a partially redundant
role in the eye. In the wing, reduction of Atro activity in
mutant clones causes cell autonomous high level expression
of Dl (and Serrate, data not shown) in clones localized in any
part of the wing pouch (Fig. 4D). Hence, both in the eye and
in the wing imaginal disc, Atro is acting as a repressor of the
EGFR target gene Dl. Note that wing notches caused by
Atro− clones (Zhang et al., 2002) can be explained by the
high levels of Dl expression in these clones (de Celis and
Bray, 1997; Micchelli et al., 1997).
Atrophin acts downstream or in parallel to the MAPK Rolled
To further investigate the role of Atro in EGFR signaling,
we analyzed the distribution of the activated form of MAPK
(dpERK) in Atro− clones (Figs. 5A–B). Activated MAPK
shows a prominent localization along the veins including
those each side of the wing margin, in the wing pouch
(Gabay et al., 1997). In the eye, high levels of expression are
observed in clusters of cells within the morphogenetic furrow
(Gabay et al., 1997). This activated MAPK distribution
reflects the activity of the EGFR via the RAS signaling
cascade. No obvious changes in dpERK staining are observed
in Atro− clones located in the eye imaginal disc (Fig. 5A).
Similarly, in Atro− clones located in the wing pouch, the
distribution of dpERK is unaffected (Fig. 5B). These results
suggest that Atro acts downstream or in parallel to MAPK in
the EGFR pathway. Moreover, we found that overexpression
of Atro suppresses the formation of extra wing-vein tissue
caused by the constitutive activated MAPK mutation rlSem
(Figs. 5C–D).
Next, we investigated whether signaling from the EGFR
influences the Atro− phenotype. To do so, we analyzed the
phenotype of Atro− clones in which EGFR signaling was
blocked. We eliminated EGFR signaling in the wing by
removing factors required for EGFR activation. In clones
mutant for both vein (vn) (Schnepp et al., 1996) and rho
(Sturtevant et al., 1993; Urban et al., 2001), veins fail to
differentiate. In triple mutant clones for vn, rho and Atro, vein
differentiation is also blocked, in contrast to Atro− clones, in
which ectopic veins are induced (compare Figs. 5G and 2H).
Consistent with this observation, no ectopic expression of the
EGFR target Dl is seen in rho−vn−Atro− mutant clones when
located in the wing pouch (Fig. 5F) contrary to Atro− mutant
clones (Fig. 4D). Thus, a positive input by EGFR signaling is
necessary for the phenotypes seen in Atro loss of function
clones. This requirement is also observed in the eye. When
the EGFR signaling is abolished in double mutant cells for
rho and roughoid (ru) (Urban et al., 2001; Wasserman et al.,
2000), PRs do not develop (data not shown and Wasserman et
al., 2000). We found that ru−rho−Atro−argos− mutant clones
lack PR cells, in contrast to Atro− argos− clones where
numerous PR are recruited (compare Figs. 2C and 5E).
Hence, in both the eye and wing pouch, loss of Atro function
is not sufficient to induce surplus EGFR signaling; EGFR
signaling is required to induce target gene output in Atro−
clones.
Fig. 3. Phenotypes of Atro overexpression. Overexpression of Atrophin antagonizes the EGFR signaling pathway. Flies were raised at either 18°C (A–C) or 25°C (D–
J). GMR-Gal4/UAS-Atro eyes (A and D) have weak (A) or medium (D) rough eye phenotypes. (B) Overactivation of EGFR signaling causes a strong rough eye
phenotype (sev-rho/sev-rho). (C) This phenotype is suppressed by overexpressing Atro (GMR-Gal4/UAS-Atro; sev-rho/sev-rho). (E) Overexpression of the EGFR
antagonist Argos under the control of the GMR enhancer (GMR-argos/+) gives a rough eye phenotype. (F) This phenotype is enhanced when Atro is co-expressed with
Argos (GMR-Gal4/UAS-Atro; GMR-argos/+). (G–I) Overexpression of Atro in the eye reduces the number of recruited cone cells. Third instar eye imaginal discs of
wild-type (G) or GMR-Gal4/UAS-Atro (H) larvae stained with anti-Cut to mark the cone cells. GMR-Gal4/UAS-Atro eyes have a reduced number of cone cells (H),
when compared to a wild-type eyes (G). Eye discs ofGMR-Gal4/UAS-Atro (I) pupae stained with anti-Arm to outline the cone cells. (I)GMR-Gal4/UAS-Atro eye discs
have a reduced number of cone cells. The arrowhead indicates an ommatidia with 3 cone cells; an ommatidia with 4 cone cells, as in wild-type eyes, is indicated by the
arrow. (J–K) Overexpression of Atro in the wing causes wing-vein suppression and reduction of the wing size. (J) Wild-type wing. Wing from 580-Gal4/UAS-Atro
flies raised 29°C (K) show loss of veins and reduced wing size. (L–M) Overexpression of Atro in the leg causes fusion of the tarsus. (M) A leg from dpp-Gal4/UAS-
Atro flies showing fusion of the tarsus. A dpp-Gal4/+ leg is shown as a control (L).
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Fig. 4. Atro negatively regulates Dl expression. (A–C) Atro cooperates with argos to repress expression of Dl in the eye. Clones of Atro− (A), argos− (B) and
argos−Atro− cells (C) in eye imaginal discs, are detected by the absence of GFP (green) and stained with anti-Dl (red). (A) The expression of Dl is weakly increased in
Atro− (A) and unaffected in argos− (B) cells, when compared to wild-type neighboring cells. (C) Ectopic expression ofDl is detected at high levels in argos−Atro− cells.
(D) Atro represses Dl expression in the wing pouch. Clones of Atro− mutant cells (D) in a wing imaginal disc, are detected by the absence of GFP (green) and stained
with anti-Dl (red). The Dl protein is ectopically produced in Atro− clones, when located in the wing pouch (D). (A–D) Each disc is visualized in different channels and
merged (left panel).
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or in parallel to MAPK to modulate the target genes that are
activated by EGFR signaling.
Atrophin interacts genetically with Yan and Pointed to repress
EGFR signaling
A variety of studies support a model where the balance
between the activities of Yan and Pnt mediates the induction
of cell differentiation via direct transcriptional control of
specific target genes (Brunner et al., 1994a; O'Neill et al.,
1994; Rebay and Rubin, 1995; Tootle et al., 2003; Xu et al.,
2000).
Atro is thought to act as a transcriptional co-repressor (Zhang
et al., 2002), hence, it could cooperate with Yan to counteract
Pnt activity in both the eye and wing pouch. We analyzedpossible genetic interactions between yan, pnt and Atro in
overexpression experiments. Overexpression of UAS-Atro with
GMR-Gal4 enhances the phenotype caused by the ectopic
expression of YanWT in the eye (Figs. 6B–D). Note that third
instar eye discs overexpressing YanWT plus Atro are normal (i.e.
these eyes display a normal number of PRs, data not shown),
hence, the effects observed in adult eyes are likely due to an
interaction occurring during the pupal stage. Next, we asked
whether Atro cooperates with Yan to counteract EGFR
signaling in the wing. To do so, we expressed an activated
form of the EGF receptor (EGFRACT) in the wing, using the
leaky activity of GMR-Gal4 in this tissue, and analyzed the
consequence of co-expressing Atro and YanWT. As expected,
expression of UAS-EGFRACT in the wing causes extra-wing
vein differentiation (Fig. 6I). Overexpression of UAS-Atro or
UAS-YanWT alone has no effect on this phenotype (Figs. 6J, K).
Fig. 5. Atro is acting downstream of the MAPK rolled. (A–B) The pattern and level of MAPK activation is not perturbed in the absence of Atro activity. Clones of
Atro− cells (A–B) in a third larval instar eye (A) or wing (B) imaginal disc, detected by the absence of GFP (green) and stained with anti-dpERK (red). (A) In the
eye, neither the intense dpERK staining seen in the morphogenetic furrow (arrow in A), nor the weak staining in differentiating cells (asterisk in A), is affected in
Atro− cells. (B) In a wing pouch containing Atro− cells, dpERK is detected along the veins including those each side of the wing margin as in wild type (data not
shown). (C–D) Overexpression of Atro suppresses the phenotype caused by constitutive activation of MAPK. (C) The gain-of-function rlSem mutation induces the
formation of ectopic veins. (D) Ubiquitous overexpression of Atro under the control of the ubiquitin promoter (ubi-GFP-Atro/+) suppresses the ectopic vein
phenotype caused by rlSem/+. (E–G) In both the eye (E) and the wing pouch (F and G), loss of Atro function is not sufficient to induce surplus EGFR signaling. (E)
Clones of ru−rho−Atro−argos− cells (marked by absence of GFP, green) in the eye imaginal disc, and stained with anti-Elav (red). ru−rho−Atro−argos− mutant clones
lack PR cells, in contrast to Atro−argos− clones where extra PRs are recruited (compare with Fig. 2C). (F) Dl is not ectopically expressed in clones of rho−vn−Atro−
mutant cells. Mutant clones, in the wing imaginal disc, are detected by the absence of GFP (green) and stained with anti-Dl (red). (F) In a rho−vn−Atro−, mutant clone
located in the wing pouch, Dl is not detected. (G) Clones mutant for vn, rho and Atro do not differentiate veins in contrast to Atro− clones where they do (compare
with Fig. 2H).
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we observed a suppression of the extra-vein phenotype
caused by UAS-EGFRACT (Fig. 6L). Note that two copies of
either UAS-YanWT or UAS-Atro do not suppress the UAS-
EGFRACT phenotype (data not shown). This indicates that
Atro and Yan cooperate genetically to inhibit signaling by
the EGFR in the wing. Furthermore, we found that reducing
pnt activity clearly enhances the rough eye phenotype
caused by Atro overexpression (Figs. 6E–H), showing that
Atro and Pnt have antagonistic activities during eye
development. However, we have not been able to co-
immunoprecipitate Yan and Atro, or Pnt and Atro, from
Drosophila S2 cells (data not shown), indicating that these
proteins may not directly bind to each other, at least in
cultured S2 cells.
Expression of mutant human Atrophin-1 mimics loss of Atro
activity in the fly
To get more insight into the function of human Atrophin-1 in
vivo, we expressed in Drosophila an NH2-terminal truncation
of expanded human Atrophin-1 (At-N917-65Q), a pathogenic
form similar to a fragment seen in a transgenic mouse model
(Nucifora et al., 2001; Schilling et al., 1999). The over-
expression of UAS-At-N917-65Q under the regulation of GMR-
Gal4 driver induced progressive eye pigment loss (Figs. 7A, B),
a phenotype often associated with expression of vertebrate
polyQ containing proteins in the Drosophila eye (Takeyama et
al., 2002; Warrick et al., 1998). We found that human At-N917-65Q is exclusively detected in nuclei, as shown in third instar
larvae eye imaginal discs (Fig. 7C). No nuclear inclusions were
observed at this developmental stage. This is in agreement with
previous work showing that overexpression of human Atrophin-
1 following transient transfection do not form aggregates
(Nucifora et al., 2003).
When expressed in the wing using the MS1096 driver or
by the leaky activity of GMR Gal4 in this tissue, UAS-At-
N917-65Q promotes ectopic vein differentiation (Figs. 7D, E).
This phenotype resembles the Atro loss of function phenotype
and is caused by overactive EGFR signaling since halving the
dose of negative regulators of EGFR pathway (such as sty,
Fig. 7G, and cic, data not shown), or heterozygotes for rlSem
(Fig. 7I), enhances this phenotype and co-expression of UAS-
EGFRDN (a dominant negative form of the EGFR) suppresses
it (Fig. 7K). We controlled the specificity of this phenotype
by overexpressing a polyQ peptide (containing 48Q) or the
exon 1 of Huntingtin with expanded polyQ (93Q). In both
cases, wing vein differentiation was not affected (data not
shown). Note, however, that overexpression of UAS-At-N917-
26Q in the wing results in a similar phenotype to UAS-At-
N917-65Q (data not shown), showing that polyQ expansion is
not essential for the phenotype caused by overexpression of
human Atrophin-1. The fact that overexpression of human At-
N917-26Q/65Q leads to a similar phenotype as loss of
Drosophila Atro, coupled with the characteristic interactions
with the EGFR signaling, raises the possibility that human
At-N917-26Q/65Q is acting as a dominant negative protein in
the fly. In support of this hypothesis, we found that halving
Fig. 6. Atro genetically interacts with yan and pointed. Flies were raised at 25°C for all panels. (A) Adult eye from GMR-Gal4/+ flies. (B-D) Atro cooperates with Yan
to inhibit eye development. (B) The eyes ofGMR-Gal4/UAS-Atro flies are rough. Eyes overexpressing YanWT (C:GMR-Gal4 UAS-YanWT/+) display a weak rough eye
phenotype. These phenotypes are enhanced when Atro is overexpressed with YanWT (D: GMR-Gal4 UAS-YanWT/UAS-Atro). (E–H) Atro and Pointed show
antagonistic activities during eye development. Reduction of Pointed activity enhanced the rough eye phenotype of GMR-Gal4/UAS-Atro flies. GMR-Gal4/+; pnt1277/
pntΔ88 (E) and GMR-Gal4/+; pnt1277/pnt07825 (G) flies display weak rough and normal eyes, respectively. These phenotypes are enhanced in flies overexpressing Atro
(F:GMR-Gal4/UAS-Atro; pnt1277/pntΔ88 and H:GMR-Gal4/UAS-Atro; pnt1277/pnt07825). (I–L) Atro and Yan cooperate to block EGFR signaling in the wing pouch. (I)
Wings from GMR-Gal4/+UAS-EGFRACT/+ flies have extra-wing vein material. Overexpression of UAS-Atro (J) or UAS-YanWT (K) have little or no effect on this
phenotype (J: GMR-Gal4/UAS-Atro; UAS-EGFRACT/+ and K: GMR-Gal4 UAS-YanWT/+; UAS-EGFRACT/+). However, the extra-vein phenotype caused by UAS-
EGFRACT is suppressed when UAS-Atro and UAS-YanWT are co-expressed (L; GMR-Gal4 UAS-YanWT/UAS-Atro; UAS-EGFRACT/+).
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by overexpression of UAS-At-N917-26Q in the wing (Fig.
7M), while ubiquitous expression of Atro suppresses it
(Fig. 7O).Fig. 7. Phenotypes of human Atrophin overexpression. Flies were raised at 29°C fo
65Q), at 4 days (A) or 15 days (B). The eyes of 4-day-old flies expressing At-N917
However, over time (B), the eye showed progressive pigment loss. Note that GMR
Atrophin-1 At-N917-65Q accumulates in nuclei of Drosophila cells. Eye imaginal dis
human Atrophin-1 antibody APG840 (red in panel C). The At-N917-65Q protein (red
human Atrophin-1 At-N917-65Q promotes wing-vein differentiation. Wings of MS1
have extra wing-vein material when compared to Wild-type (see Fig. 1F). This phe
styΔ5/+), by rlSem heterozygotes (I: GMRGal4 UAS-At-N917-65Q/rlSem) and by Atro−
+; sty−/+ (F), GMR-Gal4/rlSem (H) and GMR-Gal4/+; Atro−/+ (L) wings are shown
caused by At-N917-65Q (GMR-Gal4 UAS-At-N917-65Q/UAS-EGFRDN) (K). A GM
GFP-Atro suppresses the ectopic vein phenotype caused by At-N917-65Q (GMR-Gal
wing is shown as control (N).Discussion
Evidence that Atro contributes to the negative regulation of
EGFR signaling is as follows. First, clones mutant for Atror all panels. (A–B) Eyes expressing At-N917-65Q (GMR-Gal4/UAS-At-N917-
-65Q appeared relatively normal (A), with only slight disruption of the lattice.
-Gal4 directs expression to pigment cells as well as PR neurons. (C) Human
c from GMR-Gal4/UAS-At-N917-65Q; UAS-nlsGFP/+ flies is stained with anti-
) co-localizes with the nls-GFP fusion (green) in nuclei. (D–E) Overexpression of
096-Gal4/+; UAS-At-N917-65Q/+ (D) or GMR-Gal4 UAS-At-N917-65Q/+ (E)
notype is enhanced by sty− heterozygotes (G: GMRGal4 UAS-At-N917-65Q/+;
heterozygotes (M: GMRGal4 UAS-At-N917-65Q/+; Atro1207D6/+). GMR-Gal4/
as controls. Overexpression of EGFRDN suppresses the ectopic vein phenotype
R-Gal4/UAS-EGFRDN wing is shown as control (J). Ubiquitous expression of
4 UAS-At-N917-65Q/+; ubi-GFP-Atro/+) (O). A GMR-Gal4/+; ubi-GFP-Atro/+
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ing and express high levels of the known EGFR target gene
Dl. These effects are enhanced when negative regulators ofEGFR signaling, such as Argos, are simultaneously removed
in Atro− clones. Second, increased amounts of Atro reduce
the activity of EGFR signaling. Third ectopic expression of
288 B. Charroux et al. / Developmental Biology 291 (2006) 278–290Atro enhances the effects of decreased EGFR signaling,
whereas reduced Atro enhances the effects of ectopic
signaling. Finally, Atro genetically interacts with yan suggest-
ing that both repressors may cooperate to block EGFR
signaling output.
The likely C. elegans orthologue of Atrophin, Egl27, has
been shown to inhibit vulval development induced by the Ras
signal transduction pathway (Solari and Ahringer, 2000; Solari
et al., 1999). Thus, the role of Atro as a negative regulator of the
RTK/EGFR pathway may have been conserved during
evolution. Egl27 is a component of a repressor complex, the
nucleosome remodeling and histone deacetylase (NURD)
complex, which is composed of HDAC-1, HDAC-2, two
proteins of the Mi-2/CHD family, and MTA1 or MTA2
(reviewed in Ahringer, 2000). During vulval induction, the
NURD complex is proposed to interact with the sequence-
specific transcription factors LIN-31, an Ets-related transcrip-
tion factor and LIN-1, a winged-helix molecule. LIN-1 and
LIN-31 are repressors of vulval development that are negatively
regulated upon phosphorylation by the MAPK mpk1/sur-1 (Tan
et al., 1998).
MAPK-dependent phosphorylation of the ETS transcription
factor Pnt is necessary for the activation of the EGFR target
genes in third instar eye imaginal discs and in embryos (Brunner
et al., 1994a; Gabay et al., 1996; O'Neill et al., 1994). We found
that Yan and Atro show synergistic genetic interaction, suggesting
that both are required for the repression of EGFR signaling
function. Thus, by analogy with EGL-27 and LIN-31 from C.
elegans, we propose a model where Yan cooperates with Atro in
order to achieve tight repression. How does EGFR signaling
counteract Atro-mediated repression? Localized downregulation
(such as nuclear export and/or protein degradation) of specific
repressors is a common mechanism for the activation of target
genes by the EGFR pathway (Li et al., 1997; Mantrova and Hsu,
1998; Rebay and Rubin, 1995; Roch et al., 2002; Tsuda et al.,
2002). Two observations argue against this mechanism for the co-
repressor Atro. First, in cells with high levels of EGFR activity,
such as either side of the dorso-ventral boundary in the wing
pouch, or later in prospective veins of pupal wings, Atro protein is
detected ubiquitously and at invariant levels in all nuclei (data not
shown). Second, when EGFR signaling is overactivated in clones
(by expressing the constitutive form of EGFR, EGFRACT), the
amount and/or subcellular localization of the co-expressed Atro
protein is unchanged (data not shown).
Several lines of evidence show that, in the late phases of
imaginal disc patterning, Atro plays a specific role for EGFR
repression. We found that Atro does not contribute to other
signaling pathways during imaginal disc development. For
instance, expression of both Distal-less and the vestigial
quadrant enhancer (vgQE), two known wingless (wg) target
genes (Neumann and Cohen, 1996), is not affected in Atro−
clones located in the wing pouch (Supplementary Fig. S1). Plus,
we found that signaling from the Notch (N) receptor does not
require Atro activity since Atro− clones expressing the
constitutively active, intra-cellular fragment of the N receptor
(Nintra) display identical phenotypes to Nintra control clones,
when located in the wing pouch (see Supplementary Fig. S1).Other signaling pathways are known to affect vein differentiation
such as Decapentaplegic (DPP), which promotes vein differentia-
tion in late pupae (Martin-Blanco et al., 1999), and Nwhose activity
is necessary to restrict vein territories (de Celis and Bray, 1997).
However, we favor the idea that Atro contributes mainly to EGFR
signaling since Atro acts in third instar larvae and is dispensable for
N activity in the wing (see Supplementary Fig. S1).
Differing modes of repression of EGFR targets in the nucleus
Despite the strong correlation of Atro repression of EGFR
target genes in the imaginal discs, Atro is required for patterning
where EGFR has not been implicated. For example, Atro is
required for normal segmentation of the Drosophila embryo.
However, we note that both EGFR signaling and Atro are
required for cell survival during embryogenesis (Erkner et al.,
2002; Urban et al., 2004). Additionally, Atro is not required for
all EGFR-dependent events. For example, Atro is not involved
in the function of the EGFR defining the identity of the
proximal wing disc (Zecca and Struhl, 2002a,b) (data not
shown). These observations indicate that variable mechanisms
of control are implicated in the negative regulation of EGFR
signaling in the nucleus.
This notion is supported even in different imaginal tissues.
Tsuda et al. (2002) reported that EGFR signals via Strawberry
notch (Sno) and Ebi, to inhibit the repressor activity of a Su(H)/
SMRTER complex, leading to activation of Dl expression.
Clones of cells mutant for the Su(H)SF8, hypomorphic allele
cause high level expression of Dl in PR cells, but not in the wing
pouch (Tsuda, personal communication). We found that clones
of cells mutant for the Su(H)del47, null allele (Morel and
Schweisguth, 2000) similarly do not show ectopic expression of
Dl in the wing pouch (Supplementary Fig. S2). As expected, Su
(H)del47 cells located at the D/V border abolish the expression of
Cut (Supplementary Fig. S2). Thus, Su(H), unlike Atro, is
dispensable for Dl repression in the wing pouch. The reverse is
true in the eye, where Su(H) activity is absolutely required to
repress Dl expression (Tsuda et al., 2002) whereas Atro is less
important (Fig. 4A). This is in agreement with the weak
phenotype caused by the Atro− clones in the eye (i.e. no ectopic
PRs, few extra cone cells), and indicates a redundancy with
other negative regulators of EGFR signaling. This distinction
between the relative requirements in different tissues for
different regulators of EGFR signaling provides an interesting
insight into tissue-specific control of ubiquitous signaling
pathways. Regulators such as Atro, with functions restricted
to some tissues, may contribute to the diverse outcomes of
signaling through these common pathways.
Dentatorubral-pallidoluysian atrophy (DRPLA) is a domi-
nant, hereditary malady typified by the degeneration of specific
neurons in the brain. Although DRPLA has been mimicked in a
mouse model, the molecular and cellular mechanisms leading to
thedisease remainobscure.Ourdatapoint to the roleofAtro in the
repression of EGFR signaling. We found that expression of
human N917Atrophin-1 in the wing mimics the loss of Atro
activitywhich raises thepossibility thatN917Atrophin-1 is acting
as a dominant negative. Additionally, this phenotype is
289B. Charroux et al. / Developmental Biology 291 (2006) 278–290independent of polyQ expansion and is sensitive to the dose of
EGFR signaling components. Such effects are not seen following
expression of polyQ repeats alone or the exon 1 of Huntingtin
with expanded polyQ (93Q) in the wing, indicating that human
N917Atrophin-1 has specific effects on this pathway. This
mechanistic insight into the role of the fly genemay have broader
implications concerning Atrophin function in other organisms.Acknowledgments
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